Researchers at Hadassah University Hospital have identified that protein receptor blocker BKT140 kills cancer cells and reduces tumour growth by about 50 percent. BKT140 was developed by Biokine Therapeutics of Rehovot, originally to increase bone marrow cell production.
http://www.haaretz.com/print-edition/news/israeli-researchers-score-success-in-lung-cancer-treatment.premium-1.432249